Status:

RECRUITING

Project Dulce for Filipino-Americans With Type 2 Diabetes

Lead Sponsor:

Scripps Whittier Diabetes Institute

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

Conditions:

Diabetes Type 2

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Proje...

Detailed Description

Type 2 diabetes mellitus (T2DM) disproportionately affects racial and ethnic minority populations. Among Asian Americans, Filipino Americans (FA) have the second highest T2DM prevalence and have an in...

Eligibility Criteria

Inclusion

  • Self-identified Filipino
  • Diagnosed with T2DM
  • Registered at Scripps Health or San Ysidro Health (or willing to register)
  • HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days
  • Able to speak, read, write, and comprehend in English and Tagalog
  • Have access to a cell phone that can receive/send text messages throughout the study

Exclusion

  • Severe illness precluding frequent visits to clinic
  • Liver function tests (ALT and AST) \> 3 times the upper limit of normal
  • Body mass index ≤ 23 kg/cm
  • History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma
  • Creatinine \>3.5
  • History of drug or alcohol abuse within 12 months prior to enrollment
  • Not a permanent resident in the area
  • Current enrollee in Project Dulce
  • Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening
  • Anemia
  • Type 1 or gestational diabetes
  • Pregnant
  • Are currently participating in another diabetes-related study

Key Trial Info

Start Date :

October 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT05378620

Start Date

October 17 2022

End Date

December 31 2025

Last Update

February 4 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

San Ysidro Health

National City, California, United States, 91950

2

Scripps Whittier Diabetes Institute

San Diego, California, United States, 92037